pI: 6.3804 |
Length (AA): 706 |
MW (Da): 77400 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_134863)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_35225 | Serine/threonine-protein kinase Pim-3 |
Brugia malayi | Bm1_41540 | Protein kinase domain containing protein |
Caenorhabditis elegans | CELE_F45H7.4 | Protein PRK-2 |
Echinococcus granulosus | EgrG_000197100 | proto oncogene serine:threonine protein kinase |
Echinococcus multilocularis | EmuJ_000197100 | proto oncogene serine:threonine protein kinase |
Homo sapiens | ENSG00000198355 | Pim-3 proto-oncogene, serine/threonine kinase |
Homo sapiens | ENSG00000137193 | Pim-1 proto-oncogene, serine/threonine kinase |
Loa Loa (eye worm) | LOAG_00334 | CAMK/PIM protein kinase |
Loa Loa (eye worm) | LOAG_13501 | CAMK/PIM protein kinase |
Mus musculus | 18712 | proviral integration site 1 |
Mus musculus | ENSMUSG00000035828 | proviral integration site 3 |
Onchocerca volvulus | OVOC5800 | Serine\/threonine protein kinase homolog |
Schistosoma japonicum | Sjp_0201750 | ko:K04702 proto-oncogene serine/threonine-protein kinase Pim-1, putative |
Schistosoma mansoni | Smp_090890 | serine/threonine protein kinase |
Schmidtea mediterranea | mk4.016302.01 | Pim-2 |
Schmidtea mediterranea | mk4.004631.00 | Pim-3 |
Schmidtea mediterranea | mk4.000422.04 | |
Schmidtea mediterranea | mk4.000411.01 | |
Schmidtea mediterranea | mk4.000985.00 | Pim-1 |
Schmidtea mediterranea | mk4.007368.00 | Serine/threonine protein kinase |
Schmidtea mediterranea | mk4.017988.00 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Rattus norvegicus | Serine/threonine-protein kinase pim-3 | Compounds | References |
Homo sapiens | Pim-3 proto-oncogene, serine/threonine kinase | Compounds | References |
Homo sapiens | Pim-1 proto-oncogene, serine/threonine kinase | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Homo sapiens | Cyclin-dependent kinase 1/cyclin B1 | 297 aa | 25.6% | 293 aa | Compounds | References |
Plasmodium falciparum (isolate 3D7) | Cell division control protein 2 homolog | 288 aa | 24.3% | 296 aa | Compounds | References |
Patiria pectinifera | Cdc2 | 300 aa | 27.0% | 296 aa | Compounds | References |
Rattus norvegicus | Mitogen-activated protein kinase 1 | 358 aa | 25.3% | 324 aa | Compounds | References |